320 related articles for article (PubMed ID: 7871097)
21. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
Mele A; Thomas DN; Pert A
Neuroscience; 1998 Jan; 82(1):43-58. PubMed ID: 9483502
[TBL] [Abstract][Full Text] [Related]
22. RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors.
Fletcher PJ; Korth KM
Behav Pharmacol; 1999 Mar; 10(2):183-93. PubMed ID: 10780831
[TBL] [Abstract][Full Text] [Related]
23. Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions.
Kelley AE; Delfs JM
Psychopharmacology (Berl); 1991; 103(2):187-96. PubMed ID: 2027920
[TBL] [Abstract][Full Text] [Related]
24. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.
Hoffman DC
Pharmacol Biochem Behav; 1994 Apr; 47(4):907-12. PubMed ID: 8029261
[TBL] [Abstract][Full Text] [Related]
25. Regulation of medial prefrontal cortex dopamine by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptors.
Wu WR; Li N; Sorg BA
Neuroscience; 2002; 114(2):507-16. PubMed ID: 12204218
[TBL] [Abstract][Full Text] [Related]
26. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine.
Parkinson JA; Olmstead MC; Burns LH; Robbins TW; Everitt BJ
J Neurosci; 1999 Mar; 19(6):2401-11. PubMed ID: 10066290
[TBL] [Abstract][Full Text] [Related]
27. Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors.
David HN; Abraini JH
Neuropharmacology; 2003 May; 44(6):717-27. PubMed ID: 12681370
[TBL] [Abstract][Full Text] [Related]
28. Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area.
Cornish JL; Nakamura M; Kalivas PW
J Pharmacol Exp Ther; 2001 Jul; 298(1):226-33. PubMed ID: 11408546
[TBL] [Abstract][Full Text] [Related]
29. Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment.
Harris GC; Aston-Jones G
Neuropsychopharmacology; 2003 Jan; 28(1):73-6. PubMed ID: 12496942
[TBL] [Abstract][Full Text] [Related]
30. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats.
Biondo AM; Clements RL; Hayes DJ; Eshpeter B; Greenshaw AJ
Psychopharmacology (Berl); 2005 Apr; 179(1):189-97. PubMed ID: 15744543
[TBL] [Abstract][Full Text] [Related]
31. Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.
Fletcher PJ
Psychopharmacology (Berl); 1995 Mar; 118(2):155-63. PubMed ID: 7617802
[TBL] [Abstract][Full Text] [Related]
32. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
Ouagazzal A; Nieoullon A; Amalric M
Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
[TBL] [Abstract][Full Text] [Related]
33. Riluzole, a glutamate release inhibitor, and motor behavior.
Kretschmer BD; Kratzer U; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):181-90. PubMed ID: 9750003
[TBL] [Abstract][Full Text] [Related]
34. Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d-amphetamine-associated learning. II. Instrumental conditioning.
Hitchcott PK; Phillips GD
Psychopharmacology (Berl); 1998 Dec; 140(3):310-8. PubMed ID: 9877011
[TBL] [Abstract][Full Text] [Related]
35. Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area.
Kelley AE; Delfs JM
Psychopharmacology (Berl); 1991; 103(2):197-203. PubMed ID: 1709289
[TBL] [Abstract][Full Text] [Related]
36. Long-term enhancement of dopamine release by high frequency tetanic stimulation via a N-methyl-D-aspartate-receptor-mediated pathway in rat striatum.
Ochi M; Inoue H; Koizumi S; Shibata S; Watanabe S
Neuroscience; 1995 May; 66(1):29-36. PubMed ID: 7543663
[TBL] [Abstract][Full Text] [Related]
37. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
Kim JH; Vezina P
J Pharmacol Exp Ther; 1998 Jan; 284(1):317-22. PubMed ID: 9435194
[TBL] [Abstract][Full Text] [Related]
38. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior.
Cornish JL; Duffy P; Kalivas PW
Neuroscience; 1999; 93(4):1359-67. PubMed ID: 10501460
[TBL] [Abstract][Full Text] [Related]
39. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
Ouagazzal A; Amalric M
Eur J Pharmacol; 1995 Dec; 294(1):137-46. PubMed ID: 8788425
[TBL] [Abstract][Full Text] [Related]
40. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
